Myron Holubiak

Mr. Myron Z.
Holubiak is an Executive Vice Chairman & Secretary at Citius Oncology, Inc., an Executive Vice Chairman at Citius Pharmaceuticals, Inc. and a Chief Executive Officer at NoveCite, Inc. He is on the Board of Directors at Citius Oncology, Inc., Citius Pharmaceuticals, Inc. and Children of Chernobyl Relief Foundation.
Mr. Holubiak was previously employed as a President, Chief Executive Officer & Director by Leonard-Meron Biosciences, Inc., a Trustee by Academy of Managed Care Pharmacy, a Trustee by AMCP Foundation, an Independent Director by Intellicell Biosciences, Inc., an Independent Director by Assembly Biosciences, Inc., a Lead Independent Director by Ventrus Biosciences, Inc., a Vice Chairman by 1-800-DOCTORS, Inc., a Chairman by BioScrip, Inc., a President & Chief Operating Officer by Propel Health, LLC, a President & Chief Operating Officer by iPhysicianNet, Inc., a President by Roche Laboratories, Inc., and a Co-Founder by Emron, Inc. He also served on the board at bioAffinity Technologies, Inc., MDRNA, Inc., Chronimed, Inc., The Robert Wood Johnson Foundation and NASTech, Inc. He received his undergraduate degree from the University of Pittsburgh.